Global Viral Vector_Based Gene Therapy Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Viral Vector-Based Gene Therapy Global Market Report 2025

Name: Viral Vector-Based Gene Therapy Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Vector Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Viral Vectors), By Delivery Method (Intravenous Injection, Intrathecal Injection, Intramuscular Injection, Subcutaneous Injection, Topical Application), By Application (Oncology, Genetic Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications), By End User (Hospitals, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Viral Vector-Based Gene Therapy Market Overview

• Viral Vector-Based Gene Therapy market size has reached to $5.77 billion in 2024

• Expected to grow to $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 17%

• Growth Driver: Increasing Prevalence Of Genetic Diseases Fueling The Growth Of The Market Due To Rising Diagnosis And Awareness

• Market Trend: Integrated Systems Boost Efficiency And Reduce Costs

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Viral Vector-Based Gene Therapy Market?

Viral vector-based gene therapy is a medical approach that uses engineered viruses to deliver therapeutic genes into a patient’s cells to treat or prevent diseases. The viral vectors are modified to be safe and replication-deficient while efficiently transferring genetic material to target cells. This therapy enables correction of genetic defects, modulation of gene expression, or stimulation of immune responses to achieve long-lasting therapeutic effects.

The main vector types of viral vector-based gene therapy are adenoviral vectors, adeno-associated viral vectors, lentiviral vectors, retroviral vectors, and others. Adenoviral vectors are engineered viruses derived from adenoviruses that are modified to safely deliver therapeutic genes into target cells without replicating and are commonly used in gene therapy and vaccine applications. It is delivered through various routes, including intravenous injection, intrathecal injection, intramuscular injection, subcutaneous injection, and topical application. It finds applications in Oncology, genetic disorders, cardiovascular diseases, infectious diseases, neurological disorders, and others, serving end users such as hospitals, Clinical Research Organizations (CROs), academic and research institutes, pharmaceutical and biotechnology companies, and others.

Viral Vector_Based Gene Therapy Market Size and growth rate 2025 to 2029: Graph

What Is The Viral Vector-Based Gene Therapy Market Size and Share 2025?

What Is The Viral Vector-Based Gene Therapy Market Growth Forecast?

The viral vector-based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to growing investment in large-scale vector manufacturing, rising focus on commercial gene therapy production, increasing adoption of automation in vector processing, expansion of global biomanufacturing infrastructure, and growing collaboration between biotech and contract development and manufacturing organization (CDMO) companies. Major trends in the forecast period include technology advancements in vector design, innovations in delivery methods, developments in large-scale manufacturing, research and development in next-generation vectors, and improvements in safety and efficacy profiles.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Global Viral Vector-Based Gene Therapy Market Segmentation

1) By Vector Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Viral Vectors

2) By Delivery Method: Intravenous Injection, Intrathecal Injection, Intramuscular Injection, Subcutaneous Injection, Topical Application

3) By Application: Oncology, Genetic Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications

4) By End User: Hospitals, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Adenoviral Vectors: Human Adenovirus Serotype Five, Human Adenovirus Serotype Two, Canine Adenovirus, Other Adenoviruses

2) By Adeno-Associated Viral Vectors: Adeno-Associated Virus Serotype One, Adeno-Associated Virus Serotype Two, Adeno-Associated Virus Serotype Five, Adeno-Associated Virus Serotype Eight, Other Adeno-Associated Viruses

3) By Lentiviral Vectors: Human Immunodeficiency Virus One, Human Immunodeficiency Virus Two, Other Lentiviruses

4) By Retroviral Vectors: Gammaretrovirus, Alpharetrovirus, Spumaretrovirus, Other Retroviruses

What Is The Driver Of The Viral Vector-Based Gene Therapy Market?

The increasing prevalence of genetic diseases is expected to propel the growth of the viral vector-based gene therapy market going forward. Genetic diseases are disorders caused by changes or mutations in DNA, which can be inherited or occur spontaneously, affecting health, development, or body functions. The rising prevalence of genetic diseases is due to increased awareness and advancements in diagnostic technologies, as these enable earlier and more accurate detection of previously undiagnosed conditions. Viral vector-based gene therapy enhances genetic disease management by providing targeted delivery of therapeutic genes, making it ideal for treating inherited disorders. It reduces disease progression by enabling precise and long-lasting correction of genetic defects, improving patient outcomes and quality of life. For instance, in April 2025, according to the International Diabetes Federation (IDF), a Belgium-based non-profit organization, approximately 589 million people were living with diabetes in 2024, and this number is projected to rise to 853 million by 2050. Therefore, the increasing prevalence of genetic diseases is driving the growth of the viral vector-based gene therapy market.

Key Players In The Global Viral Vector-Based Gene Therapy Market

Major companies operating in the viral vector-based gene therapy Marketare F. Hoffmann-La Roche AG, Novartis AG, Fujifilm Holdings Corporation, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., PTC Therapeutics Inc., 4D Molecular Therapeutics Inc., Editas Medicine Inc., Regenxbio Inc., Oxford Biomedica plc, MeiraGTx Holdings plc, Voyager Therapeutics Inc., Solid Biosciences Inc., Sangamo Therapeutics Inc., Adverum Biotechnologies Inc., Passage Bio Inc., Dyno Therapeutics Inc., Genethon, uniQure N.V., Spur Therapeutics Inc.

Global Viral Vector-Based Gene Therapy Market Trends and Insights

Major companies operating in the viral vector-based gene therapy market are focusing on developing advanced platforms, such as integrated manufacturing platforms, to boost efficiency, enhance reliability, and reduce the cost and time of therapy production. Integrated manufacturing platforms refer to comprehensive systems that streamline the entire process of producing gene therapies, from vector design to final product, using standardized, high-yield processes. For instance, in October 2024, Forge Biologics Holdings LLC, a US-based biotechnology company, launched the FUEL AAV Manufacturing Platform. It is a proprietary, suspension-based manufacturing system designed to provide high productivity and scalability. It includes a fully integrated plasmid system and optimized processes, enabling robust and consistent production of adeno-associated viral (AAV) vectors for gene therapies, thereby accelerating developer timelines from research to clinical trials.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Viral Vector-Based Gene Therapy Market?

In July 2023, Sartorius AG, a Germany-based company that provides laboratory and biopharmaceutical equipment and services, acquired Polyplus SAS for an undisclosed amount. Through this acquisition, Sartorius aims to strengthen its capabilities in supplying critical transfection reagents and related technologies that enable the efficient production of viral vectors for gene and gene-modified cell therapies. Polyplus SAS is a France-based company that provides upstream technologies, products, and services for the manufacturing of viral vectors used in gene therapies.

Regional Outlook/Insights

North America was the largest region in the viral vector-based gene therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viral Vector-Based Gene Therapy Market?

The viral vector-based gene therapy market includes revenues earned by entities through process development, vector design, cell line development, assay development, process optimization, manufacturing, upstream production, and downstream purification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Viral Vector-Based Gene Therapy Industry?

The viral vector-based gene therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector-based gene therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Viral Vector-Based Gene Therapy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$6.77 billion
Revenue Forecast In 2034	$12.68 billion
Growth Rate	CAGR of 17.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Vector Type, Delivery Method, Application, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	F. Hoffmann-La Roche AG, Novartis AG, Fujifilm Holdings Corporation, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., PTC Therapeutics Inc., 4D Molecular Therapeutics Inc., Editas Medicine Inc., Regenxbio Inc., Oxford Biomedica plc, MeiraGTx Holdings plc, Voyager Therapeutics Inc., Solid Biosciences Inc., Sangamo Therapeutics Inc., Adverum Biotechnologies Inc., Passage Bio Inc., Dyno Therapeutics Inc., Genethon, uniQure N.V., Spur Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Viral Vector-Based Gene Therapy Market Characteristics

3. Viral Vector-Based Gene Therapy Market Trends And Strategies

4. Viral Vector-Based Gene Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Viral Vector-Based Gene Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Viral Vector-Based Gene Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Viral Vector-Based Gene Therapy Market Growth Rate Analysis

5.4. Global Viral Vector-Based Gene Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Viral Vector-Based Gene Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Viral Vector-Based Gene Therapy Total Addressable Market (TAM)

6. Viral Vector-Based Gene Therapy Market Segmentation

6.1. Global Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adenoviral Vectors

Adeno-Associated Viral (AAV) Vectors

Lentiviral Vectors

Retroviral Vectors

Other Viral Vectors

6.2. Global Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous Injection

Intrathecal Injection

Intramuscular Injection

Subcutaneous Injection

Topical Application

6.3. Global Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Genetic Disorders

Cardiovascular Diseases

Infectious Diseases

Neurological Disorders

Other Applications

6.4. Global Viral Vector-Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinical Research Organizations (CROs)

Academic And Research Institutes

Pharmaceutical And Biotechnology Companies

Other End Users

6.5. Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Adenovirus Serotype Five

Human Adenovirus Serotype Two

Canine Adenovirus

Other Adenoviruses

6.6. Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adeno-Associated Virus Serotype One

Adeno-Associated Virus Serotype Two

Adeno-Associated Virus Serotype Five

Adeno-Associated Virus Serotype Eight

Other Adeno-Associated Viruses

6.7. Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Immunodeficiency Virus One

Human Immunodeficiency Virus Two

Other Lentiviruses

6.8. Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Retroviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gammaretrovirus

Alpharetrovirus

Spumaretrovirus

Other Retroviruses

7. Viral Vector-Based Gene Therapy Market Regional And Country Analysis

7.1. Global Viral Vector-Based Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Viral Vector-Based Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Viral Vector-Based Gene Therapy Market

8.1. Asia-Pacific Viral Vector-Based Gene Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Viral Vector-Based Gene Therapy Market

9.1. China Viral Vector-Based Gene Therapy Market Overview

9.2. China Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Viral Vector-Based Gene Therapy Market

10.1. India Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Viral Vector-Based Gene Therapy Market

11.1. Japan Viral Vector-Based Gene Therapy Market Overview

11.2. Japan Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Viral Vector-Based Gene Therapy Market

12.1. Australia Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Viral Vector-Based Gene Therapy Market

13.1. Indonesia Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Viral Vector-Based Gene Therapy Market

14.1. South Korea Viral Vector-Based Gene Therapy Market Overview

14.2. South Korea Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Viral Vector-Based Gene Therapy Market

15.1. Western Europe Viral Vector-Based Gene Therapy Market Overview

15.2. Western Europe Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Viral Vector-Based Gene Therapy Market

16.1. UK Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Viral Vector-Based Gene Therapy Market

17.1. Germany Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Viral Vector-Based Gene Therapy Market

18.1. France Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Viral Vector-Based Gene Therapy Market

19.1. Italy Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Viral Vector-Based Gene Therapy Market

20.1. Spain Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Viral Vector-Based Gene Therapy Market

21.1. Eastern Europe Viral Vector-Based Gene Therapy Market Overview

21.2. Eastern Europe Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Viral Vector-Based Gene Therapy Market

22.1. Russia Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Viral Vector-Based Gene Therapy Market

23.1. North America Viral Vector-Based Gene Therapy Market Overview

23.2. North America Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Viral Vector-Based Gene Therapy Market

24.1. USA Viral Vector-Based Gene Therapy Market Overview

24.2. USA Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Viral Vector-Based Gene Therapy Market

25.1. Canada Viral Vector-Based Gene Therapy Market Overview

25.2. Canada Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Viral Vector-Based Gene Therapy Market

26.1. South America Viral Vector-Based Gene Therapy Market Overview

26.2. South America Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Viral Vector-Based Gene Therapy Market

27.1. Brazil Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Viral Vector-Based Gene Therapy Market

28.1. Middle East Viral Vector-Based Gene Therapy Market Overview

28.2. Middle East Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Viral Vector-Based Gene Therapy Market

29.1. Africa Viral Vector-Based Gene Therapy Market Overview

29.2. Africa Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Viral Vector-Based Gene Therapy Market Competitive Landscape And Company Profiles

30.1. Viral Vector-Based Gene Therapy Market Competitive Landscape

30.2. Viral Vector-Based Gene Therapy Market Company Profiles

30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Viral Vector-Based Gene Therapy Market Other Major And Innovative Companies

31.1. Ultragenyx Inc.

31.2. Krystal Biotech Inc.

31.3. Rocket Pharmaceuticals Inc.

31.4. PTC Therapeutics Inc.

31.5. 4D Molecular Therapeutics Inc.

31.6. Editas Medicine Inc.

31.7. Regenxbio Inc.

31.8. Oxford Biomedica plc

31.9. MeiraGTx Holdings plc

31.10. Voyager Therapeutics Inc.

31.11. Solid Biosciences Inc.

31.12. Sangamo Therapeutics Inc.

31.13. Adverum Biotechnologies Inc.

31.14. Passage Bio Inc.

31.15. Dyno Therapeutics Inc.

32. Global Viral Vector-Based Gene Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viral Vector-Based Gene Therapy Market

34. Recent Developments In The Viral Vector-Based Gene Therapy Market

35. Viral Vector-Based Gene Therapy Market High Potential Countries, Segments and Strategies

35.1 Viral Vector-Based Gene Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Viral Vector-Based Gene Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Viral Vector-Based Gene Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Viral Vector-Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Retroviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Viral Vector-Based Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Viral Vector-Based Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: F. Hoffmann-La Roche AG Financial Performance

Table 80: Novartis AG Financial Performance

Table 81: Fujifilm Holdings Corporation Financial Performance

Table 82: BioMarin Pharmaceutical Inc. Financial Performance

Table 83: Sarepta Therapeutics Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Viral Vector-Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adenoviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Adeno-Associated Viral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Lentiviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Viral Vector-Based Gene Therapy Market, Sub-Segmentation Of Retroviral Vectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Viral Vector-Based Gene Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Viral Vector-Based Gene Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Vector Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Viral Vector-Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: F. Hoffmann-La Roche AG Financial Performance

Figure 80: Novartis AG Financial Performance

Figure 81: Fujifilm Holdings Corporation Financial Performance

Figure 82: BioMarin Pharmaceutical Inc. Financial Performance

Figure 83: Sarepta Therapeutics Inc. Financial Performance

Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurologi...

Antiviral Combination Therapy Global Market Report 2025 – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase Inhibitor/...

Oral Expectorant Global Market Report 2025 – By Drug Type (Secretion Enhancer, Mucolytics), By Dosage Form (Oral Solids, Oral Liquids, Inhalants), By Medication (Prescription drugs, Over The Counter Drugs), By Distributi...

Oncolytic Virus Therapy Global Market Report 2025 – By Therapy Type (HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types),...

Viral Vector Manufacturing Global Market Report 2025 – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, Infectious ...

Viral And Non-Viral Vector Manufacturing Global Market Report 2025 – By Vector Type (Viral Vector, Non-Viral Vector), By Disease (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases), By A...

COVID-19 Current Therapy Global Market Report 2025 – By Drug Type (Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs, Others),...

Frequently Asked Questions

What is the definition of the Viral Vector-Based Gene Therapy market?

How will the Viral Vector-Based Gene Therapy market drivers and restraints affect the market dynamics? What forces will shape the Viral Vector-Based Gene Therapy industry going forward?

The market major growth driver - Increasing Prevalence Of Genetic Diseases Fueling The Growth Of The Market Due To Rising Diagnosis And Awareness. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Viral Vector-Based Gene Therapy market?

The viral vector-based gene therapy market size has grown rapidly in recent years. It will grow from $5.77 billion in 2024 to $6.77 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to increasing funding for gene therapy research, growing biopharmaceutical manufacturing capacity, rising mergers and acquisitions in the gene therapy sector, expansion of viral vector production facilities, and increasing government support for advanced therapy development. The viral vector-based gene therapy market size is expected to see rapid growth in the next few years. It will grow to $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to growing investment in large-scale vector manufacturing, rising focus on commercial gene therapy production, increasing adoption of automation in vector processing, expansion of global biomanufacturing infrastructure, and growing collaboration between biotech and contract development and manufacturing organization (CDMO) companies. Major trends in the forecast period include technology advancements in vector design, innovations in delivery methods, developments in large-scale manufacturing, research and development in next-generation vectors, and improvements in safety and efficacy profiles. For further insights on this market, request a sample here

How is the Viral Vector-Based Gene Therapy market segmented?

The viral vector-based gene therapy market covered in this report is segmented –
1) By Vector Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Viral Vectors
2) By Delivery Method: Intravenous Injection, Intrathecal Injection, Intramuscular Injection, Subcutaneous Injection, Topical Application
3) By Application: Oncology, Genetic Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Other Applications
4) By End User: Hospitals, Clinical Research Organizations (CROs), Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments:
1) By Adenoviral Vectors: Human Adenovirus Serotype Five, Human Adenovirus Serotype Two, Canine Adenovirus, Other Adenoviruses
2) By Adeno-Associated Viral Vectors: Adeno-Associated Virus Serotype One, Adeno-Associated Virus Serotype Two, Adeno-Associated Virus Serotype Five, Adeno-Associated Virus Serotype Eight, Other Adeno-Associated Viruses
3) By Lentiviral Vectors: Human Immunodeficiency Virus One, Human Immunodeficiency Virus Two, Other Lentiviruses
4) By Retroviral Vectors: Gammaretrovirus, Alpharetrovirus, Spumaretrovirus, Other Retroviruses For further insights on this market, request a sample here

Which region has the largest share of the Viral Vector-Based Gene Therapy market? What are the other regions covered in the report?

North America was the largest region in the viral vector-based gene therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector-based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Viral Vector-Based Gene Therapy market?

Major companies operating in the viral vector-based gene therapy market are F. Hoffmann-La Roche AG, Novartis AG, Fujifilm Holdings Corporation, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Inc., Krystal Biotech Inc., Rocket Pharmaceuticals Inc., PTC Therapeutics Inc., 4D Molecular Therapeutics Inc., Editas Medicine Inc., Regenxbio Inc., Oxford Biomedica plc, MeiraGTx Holdings plc, Voyager Therapeutics Inc., Solid Biosciences Inc., Sangamo Therapeutics Inc., Adverum Biotechnologies Inc., Passage Bio Inc., Dyno Therapeutics Inc., Genethon, uniQure N.V., Spur Therapeutics Inc. . For further insights on this market, request a sample here.

What are the key trends in the Viral Vector-Based Gene Therapy market?

Major trends in this market include Integrated Systems Boost Efficiency And Reduce Costs. For further insights on this market, request a sample here.